|
|
|
Volumn 166, Issue 2, 1997, Pages 129-137
|
|
Fragile X syndrome - Molecular and clinical insights and treatment issues
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBAMAZEPINE;
CLONIDINE;
DNA;
FOLIC ACID;
PSYCHOSTIMULANT AGENT;
ATTENTION DEFICIT DISORDER;
EYE DISEASE;
FEMALE;
FRAGILE X SYNDROME;
GENE MUTATION;
GENETIC COUNSELING;
HETEROZYGOTE;
HUMAN;
HYPERACTIVITY;
MALE;
MENTAL DEFICIENCY;
OTITIS MEDIA;
PATIENT EDUCATION;
PHENOTYPE;
PRENATAL DIAGNOSIS;
PREVALENCE;
REVIEW;
SEIZURE;
SLEEP DISORDER;
VOCATIONAL EDUCATION;
ADULT;
CHILD;
DIAGNOSIS, DIFFERENTIAL;
FEMALE;
FOLLOW-UP STUDIES;
FRAGILE X SYNDROME;
HUMANS;
INCIDENCE;
MALE;
MENTAL DISORDERS;
PSYCHOTROPIC DRUGS;
|
|
EID: 0030997941
PISSN: 00930415
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (33)
|
|
References (123)
|
